General Hospital Dubrovnik

Dubrovnik 20000

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Studies at this site

• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed